Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Conclusions: Calls to action for improving the life of MS patients and their families.
Walking fatigability in multiple sclerosis: A comparison between the 2- and the 6-minute walk test and an evaluation of associated factors.
The obesity-related pathology and Th17 cells.
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.
Multiple sclerosis: experimental models and reality.
Babesia parasitemia rebound after red blood cell exchange.
Resveratrol Defends Blood-brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis Mice.
Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations.
Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
[Guidelines for vaccination of immunocompromised individuals].
GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation.
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina Project.
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Dynamic impact of brief electrical nerve stimulation on the neural immune axis-polarization of macrophages toward a pro-repair phenotype in demyelinated peripheral nerve.
EP23.01: Postive postnatal outcome in pregnancy with neuromyelitis optica.
14-3-3 proteins regulate K2P 5.1 surface expression on T lymphocytes.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
A combined NMR and molecular dynamics simulation study to determine the conformational properties of rat/mouse 35-55 myelin oligodendrocyte glycoprotein epitope implicated in the induction of experimental autoimmune encephalomyelitis.
Multiple sclerosis: Rapid diagnosis or right diagnosis?
Ophthalmologic aspects of chikungunya infection.
Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
Pages
« first
‹ previous
…
729
730
731
732
733
734
735
736
737
…
next ›
last »